Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

NCT ID: NCT04351893

Last Updated: 2024-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

935 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-23

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microtia Microtia-Anotia Craniofacial Microsomia Goldenhar Syndrome OAVS OAV Syndrome Hemifacial Microsomia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Cases:

* Participant with CFM is 0-18 years of age
* Participant has diagnosis of at least one of the following conditions:

* Microtia
* Anotia
* Facial asymmetry AND preauricular tag(s)
* Facial asymmetry AND facial tag(s)
* Facial asymmetry AND epibulbar dermoid
* Facial asymmetry AND macrostomia (i.e., lateral cleft)
* Preauricular tag AND epibulbar dermoid
* Preauricular tag AND macrostomia
* Facial Tag AND epibulbar dermoid
* Macrostomia AND epibulbar dermoid
* Participant's parent or legal guardian has provided written informed consent prior to enrollment into study (for participants younger than 18 years of age).
* Participant speaks a language in which they are eligible for consent at their enrolling site

Parents:

* Parent participant is the biological parent of a case participant already eligible and participating in the CAUSE study. Non-genetic parents will be interviewed about their child's known prenatal and genetic family history but will not be asked to provide DNA or have facial photographs taken.
* Participant speaks a language in which they are eligible for consent at their enrolling site

Other relatives:

* Other relatives participants, of any age, are related biologically to a case participant already eligible and participating in the CAUSE study from a multiplex family (multiple affected individuals with CFM).
* Participant speaks a language in which they are eligible for consent at their enrolling site

EXCLUSION:

Cases:

* Participant is diagnosed with a known syndrome that involves microtia and underdevelopment of the jaw (Townes-Brocks, Treacher-Collins, Branchiootorenal, Nager, or Miller syndromes).
* Participant has abnormal chromosome studies (karyotype).
* Participant has mandibular asymmetry due to deformational plagiocephaly or torticollis.
Minimum Eligible Age

0 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Los Angeles

OTHER

Sponsor Role collaborator

Children's Hospital of Philadelphia

OTHER

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role collaborator

Pontificia Universidad Javeriana

OTHER

Sponsor Role collaborator

Universidad Icesi

OTHER

Sponsor Role collaborator

Hospital Nacional Edgardo Rebagliati Martins

OTHER

Sponsor Role collaborator

Instituto de Investigación Hospital Universitario La Paz

OTHER

Sponsor Role collaborator

Clinica Comfamiliar Risaralda

UNKNOWN

Sponsor Role collaborator

Seattle Children's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carrie Heike

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carrie Heike, MD, MS

Role: PRINCIPAL_INVESTIGATOR

Seattle Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Los Angeles

Los Angeles, California, United States

Site Status

University of North Carolina

Chapel Hill, North Carolina, United States

Site Status

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Site Status

Seattle Children's Hospital

Seattle, Washington, United States

Site Status

Pontificia Universidad Javeriana

Bogotá, , Colombia

Site Status

ICESI

Cali, , Colombia

Site Status

Pontificia Universidad Javeriana

Cali, , Colombia

Site Status

Clínica Comfamiliar Risaralda

Pereira, , Colombia

Site Status

Hospital Edgardo Rebagliati Martins

Lima, , Peru

Site Status

Instituto de Genética Médica y Molecular (INGEMM)

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Colombia Peru Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-601-E

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Li-Fraumeni Syndrome Imaging Study
NCT03176836 ENROLLING_BY_INVITATION NA